How does your brain decide what to do in a threatening situation? A new paper published in Nature describes a
Home » Brain Tumor »
Transport of lipid-conjugated floxuridine by natural serum albumin for delivery to cancer cells
How can elimination of therapeutics from the bloodstream or their early enzymatic degradation be avoided in systemic delivery? Chinese scientists
Cells stop dividing when this gene kicks into high gear: Discovery — centered on a gene called CD36 — illuminates a process tied to the aging of cells and organisms
Scientists seeking to unlock the secrets of cellular aging have identified a gene that triggers senescence, a phenomenon in which
Competition for space: Oncogenic mutant cells vs normal cells: Mechanism behind space expansion of oncogenic mutant cells
Cells in multicellular tissues adhere to each other. Epithelial tissues on the surface layer of the intestines and skin pack
Fetal T cells are first responders to infection in adults
Cornell University researchers have discovered there is a division of labor among immune cells that fight invading pathogens in the
Silence is golden when it comes to how our brains work
It’s the comparative silence between the firing spikes of neurons that tells what they are really up to, scientists report.
Scientists have captured the elusive cell that can regenerate an entire flatworm
Researchers at the Stowers Institute for Medical Research have captured the one cell that is capable of regenerating an entire
Immunization with beneficial bacteria makes brain more stress resilient
Immunization with beneficial bacteria can have long-lasting anti-inflammatory effects on the brain, making it more resilient to the physical and
New nuclear medicine method shows promise for better detection of neuroendocrine tumors
Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect cancerous gastrointestinal and pancreatic neuroendocrine
Excess zinc in muscles contributes to wasting syndrome in cancer: Discovery could lead to the development of treatments for a debilitating condition implicated in 30 percent of all cancer deaths
It’s estimated that nearly one-third of all cancer deaths are caused not by the cancer itself but by cachexia —